During your consultation at Blue Sky MD, well evaluate your medical history, current health status, and weight loss goals to determine if GLP-1 therapy is right for you
Drugs approved for weight loss include: Wegovy (injection and oral) Zepbound (KwikPen only) Foundayo (as listed in program guidance) Drugs that are NOT approved for weight loss: Ozempic and Mounjaro are not covered under the Bridge Program because the FDA approved them for diabetes treatment, not weight loss
Ephedra is an effective and result oriented metabolism booster available
For everything else better sleep, recovery, muscle gain, fat loss the boring answer is the right answer
Ozempic, Wegovy, and Mounjaro Whats the Difference
Exenatide, liraglutide, and semaglutide were associated with metabolic and nutritional AEs, and multiple GLP-1 RAs novel AE signals were identified by disproportionate analysis